Crowdhelix is helping LaserBlood expand its reach beyond the consortium by building a dedicated community [...]
Clinical partners are essential to transforming LaserBlood’s scientific ambition into clinically meaningful results. At Campus [...]
Understanding how cancer begins is key to detecting it earlier. Within LaserBlood, researchers at IRE [...]
Researchers are exploring how the protein corona – a layer of proteins that forms around [...]
Human samples are the indispensable bridge between technological innovation and clinical reality. In LaserBlood, advanced [...]
Despite the staggering ~€7 billion annual cost of pancreatic cancer in Europe, most of it [...]
Pancreatic cancer remains one of the most lethal malignancies, with a five-year survival rate lingering [...]
Despite previous failures in early pancreatic cancer detection, researchers have found hope in a disease-specific [...]
A national network of Pancreas Units is taking shape in Italy to tackle the growing [...]
Pancreatic cancer only shows symptoms in advanced stages, yet early detection methods are still absent. [...]
